Huntsman Margaret Carrell, Kurashima Courtney Kehaulani, Marikawa Yusuke
Institute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, University of Hawaii John A. Burns School of Medicine, Honolulu, HI 96813, USA.
Institute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, University of Hawaii John A. Burns School of Medicine, Honolulu, HI 96813, USA.
Reprod Toxicol. 2024 Apr;125:108558. doi: 10.1016/j.reprotox.2024.108558. Epub 2024 Feb 15.
There is growing interest in establishing alternative methods in place of conventional animal tests to assess the developmental and reproductive toxicity (DART) of chemicals. Gastruloids are 3D aggregates of pluripotent stem cells that spontaneously exhibit axial elongation morphogenesis similar to gastrulation. They have been explored as in vitro embryogenesis models for developmental and toxicological studies. Here, a mouse gastruloid-based assay was validated for DART assessment in accordance with the ICH S5(R3) guideline, which provides the plasma concentration data of various reference drugs in rodents, specifically C and AUC for NOAEL and LOAEL. First, adverse effect concentrations of the reference drugs and their known metabolites on gastruloid development were determined based on morphological impact, namely reduced growth or aberrant elongation. Then, the NOAEL to LOAEL concentration range obtained from the gastruloid assay was compared with that in rodents to examine similarities in sensitivity between the in vitro and in vivo assays for each chemical. For 18 out of the 24 reference drugs that have both NOAEL and LOAEL information in rodents, the sensitivity of the gastruloid assay was comparable to the in vivo assay within an 8-fold concentration margin. For 7 out of the 8 additional reference drugs that have only NOAEL or LOAEL information in rodents, the gastruloid assay was in line with the in vivo data. Altogether, these results support the effectiveness of the gastruloid assay, which may be exploited as a non-animal alternative method for DART assessment.
人们越来越关注建立替代传统动物试验的方法,以评估化学物质的发育和生殖毒性(DART)。原肠胚样结构是多能干细胞的三维聚集体,其自发表现出与原肠胚形成相似的轴向伸长形态发生。它们已被探索用作发育和毒理学研究的体外胚胎发生模型。在此,根据ICH S5(R3)指南验证了一种基于小鼠原肠胚样结构的试验用于DART评估,该指南提供了啮齿动物中各种参考药物的血浆浓度数据,特别是无观察到不良反应水平(NOAEL)和最低观察到有害作用水平(LOAEL)的血药浓度(C)和药时曲线下面积(AUC)。首先,根据形态学影响,即生长减少或伸长异常,确定参考药物及其已知代谢物对原肠胚样结构发育的不良反应浓度。然后,将从原肠胚样结构试验获得的NOAEL至LOAEL浓度范围与啮齿动物中的浓度范围进行比较,以检查每种化学物质的体外和体内试验在敏感性方面的相似性。对于在啮齿动物中有NOAEL和LOAEL信息的24种参考药物中的18种,原肠胚样结构试验的敏感性在8倍浓度范围内与体内试验相当。对于在啮齿动物中只有NOAEL或LOAEL信息的另外8种参考药物中的7种,原肠胚样结构试验与体内数据一致。总之,这些结果支持了原肠胚样结构试验的有效性,该试验可作为一种非动物替代方法用于DART评估。